Mantle Cell Lymphoma
📧 Sign up to get email alerts when something new happens for Mantle Cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-18Clinical Trial Results: Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3) [Phase 2]
Phase 2 trial results of Brexucabtagene Autoleucel (KTE-X19) show outcomes in relapsed/refractory mantle cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Results: Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma [Phase 2]
Phase II trial results of venetoclax plus rituximab as initial therapy in older patients with mantle cell lymphoma were reported.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event [NA]
ClinicalTrials.gov update describes a study on continuous temperature monitoring to detect cytokine release syndrome during immunotherapy, w…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: The Efficacy and Safety of Sonrotoclax, Zanubrutinib Combined With Obinutuzumab in MCL [Phase 1]
A Phase 1 trial evaluating the combination of Sonrotoclax, Zanubrutinib, and Obinutuzumab in intermediate-to-high-risk Mantle Cell Lymphoma,…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study Comparing Rituximab/Bendamustin(RB) Alternating With Rituximab/Bendamustin/Cytarabin(RBAC) With RB Therapy in Elderly Patients With Mentle Cell Lymphoma [Phase 2]
A Phase 2 trial compares Rituximab/Bendamustine alternating therapy with Rituximab/Bendamustine/Cytarabine therapy versus RB alone in elderl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL) [Phase 3]
Phase 3 clinical trial evaluating Sonrotoclax plus Zanubrutinib versus placebo plus Zanubrutinib in adults with relapsed/refractory mantle c…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Phase II Study of Pirtobrutinib, Rituximab (PR) in Previously Untreated Low and Intermediate Risk MCL (Mantle Cell Lymphoma) Patients [Phase 2]
Phase II trial evaluating pirtobrutinib in combination with rituximab for previously untreated low- and intermediate-risk mantle cell lympho…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma [Phase 2]
This clinical trial update describes a Phase 2 study of a triple therapy (Sonrotoclax, Rituximab, and Zanubrutinib) for chronic lymphocytic …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies [Phase 1, Phase 2]
This is a Phase 1/2 dose-escalation and expansion study of BGB-16673 in patients with various B-cell malignancies and is currently recruitin…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the triplet combination venetoclax, lenalidomide, and rituximab in patients with previously untreated ma…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers [Phase 1]
This document outlines an ongoing Phase 1 trial evaluating NKX019, an allogeneic CAR NK cell therapy, in adults with B-cell cancers includin…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of Acalabrutinib in Combination With Rituximab + (Bendamustine or Venetoclax) in Subjects With MCL [Phase 1]
A Phase 1 trial is evaluating acalabrutinib in combination with rituximab and either bendamustine or venetoclax in patients with mantle cell…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 clinical trial update evaluating zanubrutinib in combination with sonrotoclax for relapsed or refractory B-cell non-Hodgkin lymphoma…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of Copanlisib and Venetoclax for relapsed or refractory mantle cell lymphoma, currentl…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma [Phase 2]
A Phase 2 study evaluating glofitamab with pirtobrutinib for relapsed or refractory mantle cell lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
This observational study investigates cardiac arrhythmias in patients treated with BTK inhibitors or venetoclax in chronic lymphocytic leuke…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial update for BGB-16673, a BTK-targeted protein degrader, in Chinese participants with various B-cell malignan…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy [Phase 2]
A Phase 2 clinical trial investigating glofitamab in mantle cell lymphoma patients who had inadequate response or relapse after CAR-T therap…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy [Phase 2]
A Phase 2 clinical trial is evaluating glofitamab in mantle cell lymphoma patients whose disease returned after CAR-T therapy, and the study…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Acalabrutinib for the Treatment of Ibrutinib-Intolerant Mantle Cell Lymphoma [Phase 2]
Clinical trial update indicates a phase 2 study of Calquence (acalabrutinib) for ibrutinib-intolerant mantle cell lymphoma is active but not…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study [Phase 2]
Phase 2 trial investigating induction with a Bruton tyrosine kinase inhibitor and rituximab followed by glofitamab consolidation in high-ris…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma [Phase 2]
This update describes a Phase II multicenter study evaluating pirtobrutinib, rituximab, and venetoclax in patients with previously untreated…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients [Phase 2]
Phase II clinical trial evaluating the combination of pirtobrutinib with venetoclax in relapsed/refractory mantle cell lymphoma is currently…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial update describes autologous stem cell transplant followed by polatuzumab vedotin for patients with various B-cell…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies [Phase 1]
NX-5948 is being studied in a Phase 1 trial for adults with relapsed/refractory B-cell malignancies; the study is currently recruiting.